DOI record:
{
"DOI": "10.1186/s12985-023-02195-9",
"ISSN": [
"1743-422X"
],
"URL": "http://dx.doi.org/10.1186/s12985-023-02195-9",
"abstract": "<jats:title>Abstract</jats:title><jats:sec>\n <jats:title>Purpose</jats:title>\n <jats:p>Despite the extensive vaccination campaigns in many countries, COVID-19 is still a major worldwide health problem because of its associated morbidity and mortality. Therefore, finding efficient treatments as fast as possible is a pressing need. Drug repurposing constitutes a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case with COVID-19.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Methods</jats:title>\n <jats:p>Using data from a central registry of electronic health records (the Andalusian Population Health Database), the effect of prior consumption of drugs for other indications previous to the hospitalization with respect to patient outcomes, including survival and lymphocyte progression, was studied on a retrospective cohort of 15,968 individuals, comprising all COVID-19 patients hospitalized in Andalusia between January and November 2020.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Results</jats:title>\n <jats:p>Covariate-adjusted hazard ratios and analysis of lymphocyte progression curves support a significant association between consumption of 21 different drugs and better patient survival. Contrarily, one drug, furosemide, displayed a significant increase in patient mortality.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Conclusions</jats:title>\n <jats:p>In this study we have taken advantage of the availability of a regional clinical database to study the effect of drugs, which patients were taking for other indications, on their survival. The large size of the database allowed us to control covariates effectively.</jats:p>\n </jats:sec>",
"alternative-id": [
"2195"
],
"article-number": "226",
"assertion": [
{
"group": {
"label": "Article History",
"name": "ArticleHistory"
},
"label": "Received",
"name": "received",
"order": 1,
"value": "6 December 2022"
},
{
"group": {
"label": "Article History",
"name": "ArticleHistory"
},
"label": "Accepted",
"name": "accepted",
"order": 2,
"value": "27 September 2023"
},
{
"group": {
"label": "Article History",
"name": "ArticleHistory"
},
"label": "First Online",
"name": "first_online",
"order": 3,
"value": "6 October 2023"
},
{
"group": {
"label": "Declarations",
"name": "EthicsHeading"
},
"name": "Ethics",
"order": 1
},
{
"group": {
"label": "Competing interests",
"name": "EthicsHeading"
},
"name": "Ethics",
"order": 2,
"value": "The authors declare no competing interests."
},
{
"group": {
"label": "Ethics approval",
"name": "EthicsHeading"
},
"name": "Ethics",
"order": 3,
"value": "This project was reviewed and approved by the Ethics Committee for the Coordination of Biomedical Research in Andalusia (29th September, 2020, Acta 09/20)."
},
{
"group": {
"label": "Conflict of interest",
"name": "EthicsHeading"
},
"name": "Ethics",
"order": 4,
"value": "The authors have no competing interests to declare that are relevant to the content of this article."
}
],
"author": [
{
"ORCID": "http://orcid.org/0000-0001-9598-6965",
"affiliation": [],
"authenticated-orcid": false,
"family": "Loucera",
"given": "Carlos",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-4235-2886",
"affiliation": [],
"authenticated-orcid": false,
"family": "Carmona",
"given": "Rosario",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-2632-9587",
"affiliation": [],
"authenticated-orcid": false,
"family": "Esteban-Medina",
"given": "Marina",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-1690-6347",
"affiliation": [],
"authenticated-orcid": false,
"family": "Bostelmann",
"given": "Gerrit",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Muñoyerro-Muñiz",
"given": "Dolores",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-0845-0172",
"affiliation": [],
"authenticated-orcid": false,
"family": "Villegas",
"given": "Román",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-6445-9617",
"affiliation": [],
"authenticated-orcid": false,
"family": "Peña-Chilet",
"given": "María",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-3318-120X",
"affiliation": [],
"authenticated-orcid": false,
"family": "Dopazo",
"given": "Joaquín",
"sequence": "additional"
}
],
"container-title": "Virology Journal",
"container-title-short": "Virol J",
"content-domain": {
"crossmark-restriction": false,
"domain": [
"link.springer.com"
]
},
"created": {
"date-parts": [
[
2023,
10,
6
]
],
"date-time": "2023-10-06T17:02:10Z",
"timestamp": 1696611730000
},
"deposited": {
"date-parts": [
[
2023,
10,
6
]
],
"date-time": "2023-10-06T17:02:38Z",
"timestamp": 1696611758000
},
"funder": [
{
"DOI": "10.13039/501100010566",
"award": [
"PAIDI2020- DOC_00350",
"COVID-0012-2020"
],
"doi-asserted-by": "crossref",
"name": "Consejería de Salud y Familias, Junta de Andalucía"
},
{
"DOI": "10.13039/501100004837",
"award": [
"PID2020-117979RB-I00"
],
"doi-asserted-by": "crossref",
"name": "Ministerio de Ciencia e Innovación"
},
{
"DOI": "10.13039/501100004587",
"award": [
"IMP/00019"
],
"doi-asserted-by": "crossref",
"name": "Instituto de Salud Carlos III"
}
],
"indexed": {
"date-parts": [
[
2023,
10,
7
]
],
"date-time": "2023-10-07T18:13:57Z",
"timestamp": 1696702437209
},
"is-referenced-by-count": 0,
"issue": "1",
"issued": {
"date-parts": [
[
2023,
10,
6
]
]
},
"journal-issue": {
"issue": "1",
"published-online": {
"date-parts": [
[
2023,
12
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2023,
10,
6
]
],
"date-time": "2023-10-06T00:00:00Z",
"timestamp": 1696550400000
}
},
{
"URL": "https://creativecommons.org/licenses/by/4.0",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2023,
10,
6
]
],
"date-time": "2023-10-06T00:00:00Z",
"timestamp": 1696550400000
}
}
],
"link": [
{
"URL": "https://link.springer.com/content/pdf/10.1186/s12985-023-02195-9.pdf",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://link.springer.com/article/10.1186/s12985-023-02195-9/fulltext.html",
"content-type": "text/html",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://link.springer.com/content/pdf/10.1186/s12985-023-02195-9.pdf",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "297",
"original-title": [],
"prefix": "10.1186",
"published": {
"date-parts": [
[
2023,
10,
6
]
]
},
"published-online": {
"date-parts": [
[
2023,
10,
6
]
]
},
"publisher": "Springer Science and Business Media LLC",
"reference": [
{
"DOI": "10.1136/bmj.n826",
"doi-asserted-by": "crossref",
"key": "2195_CR1",
"unstructured": "Wood A, Denholm R, Hollings S, Cooper J, Ip S, Walker V et al. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource. BMJ. 2021;373."
},
{
"DOI": "10.1001/jama.2018.10136",
"author": "J Corrigan-Curay",
"doi-asserted-by": "publisher",
"key": "2195_CR2",
"unstructured": "Corrigan-Curay J, Sacks L, Woodcock J. JAMA: the journal of the American Medical Association. 2018;320(9):867–8. https://doi.org/10.1001/jama.2018.10136. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness.",
"year": "2018"
},
{
"DOI": "10.1056/NEJMsb1609216",
"author": "RE Sherman",
"doi-asserted-by": "publisher",
"first-page": "2293",
"issue": "23",
"journal-title": "N Engl J Med",
"key": "2195_CR3",
"unstructured": "Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence—what is it and what can it tell us. N Engl J Med. 2016;375(23):2293–7.",
"volume": "375",
"year": "2016"
},
{
"author": "EL Hannan",
"first-page": "211",
"issue": "3",
"journal-title": "JACC: Cardiovasc Interventions",
"key": "2195_CR4",
"unstructured": "Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC: Cardiovasc Interventions. 2008;1(3):211–7.",
"volume": "1",
"year": "2008"
},
{
"DOI": "10.1007/s00392-016-1025-6",
"author": "MR Cowie",
"doi-asserted-by": "publisher",
"first-page": "1",
"issue": "1",
"journal-title": "Clin Res Cardiol",
"key": "2195_CR5",
"unstructured": "Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, et al. Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1–9.",
"volume": "106",
"year": "2017"
},
{
"DOI": "10.1038/s41598-021-02701-5",
"author": "C Loucera",
"doi-asserted-by": "publisher",
"first-page": "1",
"issue": "1",
"journal-title": "Sci Rep",
"key": "2195_CR6",
"unstructured": "Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, Lopez-Miranda J, et al. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized andalusian patients. Sci Rep. 2021;11(1):1–12.",
"volume": "11",
"year": "2021"
},
{
"DOI": "10.1016/j.gaceta.2019.03.003",
"author": "D Muñoyerro-Muñiz",
"doi-asserted-by": "publisher",
"first-page": "105",
"issue": "2",
"journal-title": "Gac Sanit",
"key": "2195_CR7",
"unstructured": "Muñoyerro-Muñiz D, Goicoechea-Salazar J, García-León F, Laguna-Tellez A, Larrocha-Mata D, Cardero-Rivas M. Health record linkage: andalusian health population database. Gac Sanit. 2019;34(2):105–13.",
"volume": "34",
"year": "2019"
},
{
"key": "2195_CR8",
"unstructured": "Infrastructure for secure generation of. Real World Evidence from Real World Data from the Andalusian Health Population Database. 2020."
},
{
"DOI": "10.1038/s41392-020-00417-y",
"author": "C Loucera",
"doi-asserted-by": "publisher",
"first-page": "290",
"issue": "1",
"journal-title": "Signal Transduct Target Therapy",
"key": "2195_CR9",
"unstructured": "Loucera C, Esteban-Medina M, Rian K, Falco MM, Dopazo J, Peña-Chilet M. Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection. Signal Transduct Target Therapy. 2020;5(1):290. https://doi.org/10.1038/s41392-020-00417-y.",
"volume": "5",
"year": "2020"
},
{
"DOI": "10.1186/s13040-021-00234-1",
"author": "K Rian",
"doi-asserted-by": "publisher",
"first-page": "1",
"issue": "1",
"journal-title": "BioData Min",
"key": "2195_CR10",
"unstructured": "Rian K, Esteban-Medina M, Hidalgo MR, Çubuk C, Falco MM, Loucera C, et al. Mechanistic modeling of the SARS-CoV-2 disease map. BioData Min. 2021;14(1):1–8.",
"volume": "14",
"year": "2021"
},
{
"DOI": "10.15252/msb.202110387",
"author": "M Ostaszewski",
"doi-asserted-by": "publisher",
"first-page": "e10387",
"issue": "10",
"journal-title": "Mol Syst Biol",
"key": "2195_CR11",
"unstructured": "Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A, et al. COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms. Mol Syst Biol. 2021;17(10):e10387. https://doi.org/10.15252/msb.202110387.",
"volume": "17",
"year": "2021"
},
{
"DOI": "10.1016/j.ejim.2022.01.031",
"author": "JF Varona",
"doi-asserted-by": "publisher",
"first-page": "106",
"journal-title": "Eur J Intern Med",
"key": "2195_CR12",
"unstructured": "Varona JF, Núñez E, Fernández Félix BM, Castellano Vázquez JM, Cubillo A. Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia. Eur J Intern Med. 2022;99:106–8. https://doi.org/10.1016/j.ejim.2022.01.031.",
"volume": "99",
"year": "2022"
},
{
"DOI": "10.1016/j.eclinm.2021.100774",
"author": "C Pawlowski",
"doi-asserted-by": "publisher",
"first-page": "100774",
"journal-title": "EClinicalMedicine",
"key": "2195_CR13",
"unstructured": "Pawlowski C, Venkatakrishnan A, Kirkup C, Berner G, Puranik A, O’Horo JC, et al. Enoxaparin is associated with lower rates of mortality than unfractionated heparin in hospitalized COVID-19 patients. EClinicalMedicine. 2021;33:100774.",
"volume": "33",
"year": "2021"
},
{
"DOI": "10.3390/nu14194217",
"doi-asserted-by": "publisher",
"key": "2195_CR14",
"unstructured": "Olczak-Pruc M, Swieczkowski D, Ladny JR, Pruc M, Juarez-Vela R, Rafique Z, et al. Vitamin C supplementation for the treatment of COVID-19: a systematic review and Meta-analysis. Nutrients. 2022;14(19). https://doi.org/10.3390/nu14194217."
},
{
"DOI": "10.1253/circj.cj-10-0110",
"author": "Q Zhou",
"doi-asserted-by": "publisher",
"first-page": "818",
"issue": "5",
"journal-title": "Circulation Journal: Official Journal of the Japanese Circulation Society",
"key": "2195_CR15",
"unstructured": "Zhou Q, Liao JK. Pleiotropic effects of statins. - basic research and clinical perspectives. Circulation Journal: Official Journal of the Japanese Circulation Society. 2010;74(5):818–26. https://doi.org/10.1253/circj.cj-10-0110.",
"volume": "74",
"year": "2010"
},
{
"DOI": "10.3389/fcvm.2022.820260",
"doi-asserted-by": "crossref",
"key": "2195_CR16",
"unstructured": "Kouhpeikar H, Tabasi HK, Khazir Z, Naghipour A, Moghadam HM, Forouzanfar H et al. Statin use in COVID-19 hospitalized patients and outcomes: a retrospective study. Front Cardiovasc Med. 2022;9."
},
{
"DOI": "10.3389/fimmu.2022.820131",
"doi-asserted-by": "crossref",
"key": "2195_CR17",
"unstructured": "Teixeira L, Temerozo JR, Pereira-Dutra FS, Ferreira AC, Mattos M, Gonçalves BS et al. Simvastatin downregulates the SARS-CoV-2-Induced inflammatory response and impairs viral infection through disruption of lipid rafts. Front Immunol. 2022;13."
},
{
"DOI": "10.1186/s41231-021-00102-4",
"author": "S Umakanthan",
"doi-asserted-by": "publisher",
"first-page": "22",
"issue": "1",
"journal-title": "Transl Med Commun",
"key": "2195_CR18",
"unstructured": "Umakanthan S, Senthil S, John S, Madhavan MK, Das J, Patil S, et al. The protective role of statins in COVID-19 patients: a retrospective observational study. Transl Med Commun. 2021;6(1):22. https://doi.org/10.1186/s41231-021-00102-4.",
"volume": "6",
"year": "2021"
},
{
"DOI": "10.1080/00325481.1989.11700602",
"author": "G Ruoff",
"doi-asserted-by": "publisher",
"first-page": "127",
"issue": "3",
"journal-title": "Postgrad Med",
"key": "2195_CR19",
"unstructured": "Ruoff G. ACE inhibitors and diuretics. The benefits of combined therapy for hypertension. Postgrad Med. 1989;85(3):127–32. https://doi.org/10.1080/00325481.1989.11700602. 37 – 9.",
"volume": "85",
"year": "1989"
},
{
"DOI": "10.1038/s41440-020-0485-2",
"author": "S Huang",
"doi-asserted-by": "publisher",
"first-page": "824",
"issue": "8",
"journal-title": "Hypertens Res",
"key": "2195_CR20",
"unstructured": "Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020;43(8):824–31.",
"volume": "43",
"year": "2020"
},
{
"DOI": "10.1097/fjc.0000000000001116",
"author": "M Peng",
"doi-asserted-by": "publisher",
"first-page": "e648",
"issue": "5",
"journal-title": "J Cardiovasc Pharmacol",
"key": "2195_CR21",
"unstructured": "Peng M, He J, Xue Y, Yang X, Liu S, Gong Z. Role of hypertension on the severity of COVID-19: a review. J Cardiovasc Pharmacol. 2021;78(5):e648–e55. https://doi.org/10.1097/fjc.0000000000001116.",
"volume": "78",
"year": "2021"
},
{
"key": "2195_CR22",
"unstructured": "Chappell L, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al. Dexamethasone in hospitalized patients with Covid-19-preliminary report. The New England journal of medicine. 2020."
},
{
"DOI": "10.1136/bmj.m1086",
"doi-asserted-by": "crossref",
"key": "2195_CR23",
"unstructured": "Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. British Medical Journal Publishing Group; 2020."
},
{
"DOI": "10.1007/s40264-021-01089-5",
"author": "N Moore",
"doi-asserted-by": "publisher",
"first-page": "929",
"issue": "9",
"journal-title": "Drug Saf",
"key": "2195_CR24",
"unstructured": "Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID-19: a systematic review and meta-analysis. Drug Saf. 2021;44(9):929–38.",
"volume": "44",
"year": "2021"
},
{
"DOI": "10.1177/135965350601100803",
"author": "C Amici",
"doi-asserted-by": "publisher",
"first-page": "1021",
"issue": "8",
"journal-title": "Antivir Ther",
"key": "2195_CR25",
"unstructured": "Amici C, Caro AD, Ciucci A, Chiappa L, Castilletti C, Martella V, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021–30.",
"volume": "11",
"year": "2006"
},
{
"DOI": "10.1177/2515690X211003727",
"author": "ZD Kifle",
"doi-asserted-by": "publisher",
"first-page": "2515690X2110037",
"journal-title": "J Evidence-Based Integr Med",
"key": "2195_CR26",
"unstructured": "Kifle ZD, Enyew EF, Mekuria AB. A recent achievement in the discovery and development of vaccines and therapeutic agents in the race for COVID-19 protection and treatment. J Evidence-Based Integr Med. 2021;26:2515690X211003727.",
"volume": "26",
"year": "2021"
},
{
"DOI": "10.1080/22221751.2020.1807885",
"author": "Y Li",
"doi-asserted-by": "publisher",
"first-page": "1869",
"issue": "1",
"journal-title": "Emerg Microbes Infect",
"key": "2195_CR27",
"unstructured": "Li Y, Zhou X, Li T, Chan S, Yu Y, Ai JW, et al. Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study. Emerg Microbes Infect. 2020;9(1):1869–77. https://doi.org/10.1080/22221751.2020.1807885.",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.21037/atm.2016.10.36",
"doi-asserted-by": "crossref",
"key": "2195_CR28",
"unstructured": "MacIsaac RJ, Jerums G, Ekinci EI. Cardio-renal protection with empagliflozin. Annals of Translational Medicine. 2016;4(20)."
},
{
"DOI": "10.1177/08971900221102119",
"author": "EM Mikhael",
"doi-asserted-by": "publisher",
"first-page": "980",
"issue": "4",
"journal-title": "J Pharm Pract",
"key": "2195_CR29",
"unstructured": "Mikhael EM, Ong SC, Sheikh Ghadzi SM. Efficacy and safety of Sitagliptin in the treatment of COVID-19. J Pharm Pract. 2023;36(4):980–7. https://doi.org/10.1177/08971900221102119.",
"volume": "36",
"year": "2023"
},
{
"DOI": "10.1371/journal.ppat.1009634",
"author": "E Varghese",
"doi-asserted-by": "publisher",
"first-page": "e1009634",
"issue": "6",
"journal-title": "PLoS Pathog",
"key": "2195_CR30",
"unstructured": "Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): molecular mechanism of metformin intervention and the scientific basis of drug repurposing. PLoS Pathog. 2021;17(6):e1009634. https://doi.org/10.1371/journal.ppat.1009634.",
"volume": "17",
"year": "2021"
},
{
"DOI": "10.1016/S2213-2600(21)00160-0",
"author": "S Ramakrishnan",
"doi-asserted-by": "publisher",
"first-page": "763",
"issue": "7",
"journal-title": "The Lancet Respiratory Medicine",
"key": "2195_CR31",
"unstructured": "Ramakrishnan S, Nicolau DV, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. 2021;9(7):763–72.",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(21)01744-X",
"author": "L-M Yu",
"doi-asserted-by": "publisher",
"first-page": "843",
"issue": "10303",
"journal-title": "The Lancet",
"key": "2195_CR32",
"unstructured": "Yu L-M, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. The Lancet. 2021;398(10303):843–55. https://doi.org/10.1016/S0140-6736(21)01744-X.",
"volume": "398",
"year": "2021"
},
{
"DOI": "10.3389/fphar.2023.1185076",
"author": "Y Yu",
"doi-asserted-by": "publisher",
"first-page": "1185076",
"journal-title": "Front Pharmacol",
"key": "2195_CR33",
"unstructured": "Yu Y, Fang B, Yang X-D, Zheng Y. One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19. Front Pharmacol. 2023;14:1185076.",
"volume": "14",
"year": "2023"
},
{
"DOI": "10.1183/09031936.00159708",
"author": "M Wijesinghe",
"doi-asserted-by": "publisher",
"first-page": "803",
"issue": "4",
"journal-title": "Eur Respir J",
"key": "2195_CR34",
"unstructured": "Wijesinghe M, Weatherall M, Perrin K, Harwood M, Beasley R. Risk of mortality associated with formoterol: a systematic review and meta-analysis. Eur Respir J. 2009;34(4):803–11. https://doi.org/10.1183/09031936.00159708.",
"volume": "34",
"year": "2009"
},
{
"DOI": "10.3389/fphar.2023.1187818",
"author": "S Zhou",
"doi-asserted-by": "publisher",
"first-page": "1187818",
"journal-title": "Front Pharmacol",
"key": "2195_CR35",
"unstructured": "Zhou S, Yu Z, Chen Z, Ning F, Hu X, Wu T, et al. Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1. Front Pharmacol. 2023;14:1187818. https://doi.org/10.3389/fphar.2023.1187818.",
"volume": "14",
"year": "2023"
},
{
"DOI": "10.1055/a-1236-3041",
"author": "A Ray",
"doi-asserted-by": "publisher",
"first-page": "484",
"issue": "10",
"journal-title": "Drug Res (Stuttg)",
"key": "2195_CR36",
"unstructured": "Ray A, Sharma S, Sadasivam B. The potential therapeutic role of Proton Pump inhibitors in COVID-19: hypotheses based on existing evidences. Drug Res (Stuttg). 2020;70(10):484–8. https://doi.org/10.1055/a-1236-3041.",
"volume": "70",
"year": "2020"
},
{
"DOI": "10.3390/antibiotics11081063",
"doi-asserted-by": "publisher",
"key": "2195_CR37",
"unstructured": "Kournoutou GG, Dinos G. Azithromycin through the Lens of the COVID-19 treatment. Antibiot (Basel). 2022;11(8). https://doi.org/10.3390/antibiotics11081063."
},
{
"DOI": "10.3399/bjgpopen20X101094",
"doi-asserted-by": "crossref",
"key": "2195_CR38",
"unstructured": "Gbinigie K, Frie K. Should azithromycin be used to treat COVID-19? A rapid review. BJGP open. 2020;4(2)."
},
{
"DOI": "10.1001/jama.2020.17023",
"author": "JA Sterne",
"doi-asserted-by": "publisher",
"first-page": "1330",
"issue": "13",
"journal-title": "JAMA: The Journal of the American Medical Association",
"key": "2195_CR39",
"unstructured": "Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA: The Journal of the American Medical Association. 2020;324(13):1330–41.",
"volume": "324",
"year": "2020"
},
{
"DOI": "10.1038/s41380-021-01021-4",
"author": "N Hoertel",
"doi-asserted-by": "publisher",
"first-page": "5199",
"issue": "9",
"journal-title": "Mol Psychiatry",
"key": "2195_CR40",
"unstructured": "Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26(9):5199–212.",
"volume": "26",
"year": "2021"
},
{
"DOI": "10.1016/S1473-3099(21)00019-0",
"author": "B Gutiérrez-Gutiérrez",
"doi-asserted-by": "publisher",
"journal-title": "Lancet Infect Dis",
"key": "2195_CR41",
"unstructured": "Gutiérrez-Gutiérrez B, del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021. https://doi.org/10.1016/S1473-3099(21)00019-0.",
"year": "2021"
},
{
"DOI": "10.1162/003465304323023651",
"author": "GW Imbens",
"doi-asserted-by": "publisher",
"first-page": "4",
"issue": "1",
"journal-title": "Rev Econ Stat",
"key": "2195_CR42",
"unstructured": "Imbens GW. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat. 2004;86(1):4–29.",
"volume": "86",
"year": "2004"
},
{
"DOI": "10.1002/bimj.201700330",
"author": "D Hajage",
"doi-asserted-by": "publisher",
"first-page": "1151",
"issue": "6",
"journal-title": "Biom J",
"key": "2195_CR43",
"unstructured": "Hajage D, Chauvet G, Belin L, Lafourcade A, Tubach F, De Rycke Y. Closed-form variance estimator for weighted propensity score estimators with survival outcome. Biom J. 2018;60(6):1151–63.",
"volume": "60",
"year": "2018"
},
{
"DOI": "10.1038/s41392-020-00451-w",
"author": "C Lu",
"doi-asserted-by": "crossref",
"first-page": "1",
"issue": "1",
"journal-title": "Signal Transduct Target Therapy",
"key": "2195_CR44",
"unstructured": "Lu C, Liu Y, Chen B, Yang H, Hu H, Zhao Y. Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment. Signal Transduct Target Therapy. 2021;6(1):1–3.",
"volume": "6",
"year": "2021"
},
{
"DOI": "10.1371/journal.pone.0248276",
"author": "L Manenti",
"doi-asserted-by": "publisher",
"first-page": "e0248276",
"issue": "3",
"journal-title": "PLoS ONE",
"key": "2195_CR45",
"unstructured": "Manenti L, Maggiore U, Fiaccadori E, Meschi T, Antoni AD, Nouvenne A, et al. Reduced mortality in COVID-19 patients treated with colchicine: results from a retrospective, observational study. PLoS ONE. 2021;16(3):e0248276. https://doi.org/10.1371/journal.pone.0248276.",
"volume": "16",
"year": "2021"
},
{
"author": "A Kuznetsova",
"first-page": "1",
"issue": "1",
"journal-title": "J Stat Softw",
"key": "2195_CR46",
"unstructured": "Kuznetsova A, Brockhoff PB, Christensen RH. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(1):1–26.",
"volume": "82",
"year": "2017"
},
{
"DOI": "10.1016/j.jclinepi.2013.01.013",
"author": "EA Stuart",
"doi-asserted-by": "publisher",
"first-page": "84",
"issue": "8",
"journal-title": "J Clin Epidemiol",
"key": "2195_CR47",
"unstructured": "Stuart EA, Lee BK, Leacy FP. Prognostic score–based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8):84–S90. e1.",
"volume": "66",
"year": "2013"
},
{
"key": "2195_CR48",
"unstructured": "Greifer N, WeightIt. Weighting for Covariate Balance in Observational Studies. 2021."
},
{
"key": "2195_CR49",
"unstructured": "Greifer N. cobalt: Covariate Balance Tables and Plots. 2021."
},
{
"author": "Y Benjamini",
"first-page": "289",
"issue": "1",
"journal-title": "J Royal Stat Soc Ser B",
"key": "2195_CR50",
"unstructured": "Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B. 1995;57(1):289–300.",
"volume": "57",
"year": "1995"
},
{
"key": "2195_CR51",
"unstructured": "Hajage D, HrIPW. Hazard Ratio Estimation using Cox Model Weighted by the Estimated Propensity Score. 2020."
},
{
"DOI": "10.18637/jss.v067.i01",
"author": "D Bates",
"doi-asserted-by": "publisher",
"first-page": "1",
"journal-title": "J Stat Softw",
"key": "2195_CR52",
"unstructured": "Bates D, Maechler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1–48.",
"volume": "67",
"year": "2015"
}
],
"reference-count": 52,
"references-count": 52,
"relation": {
"references": [
{
"asserted-by": "subject",
"id": "",
"id-type": "uri"
}
]
},
"resource": {
"primary": {
"URL": "https://virologyj.biomedcentral.com/articles/10.1186/s12985-023-02195-9"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Infectious Diseases",
"Virology"
],
"subtitle": [],
"title": "Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
"volume": "20"
}
